Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
India's drug regulator CDSCO refuses to disclose risk-based inspection details under RTI, sparking debate on transparency vs. commercial interests. Experts warn this secrecy endangers public health.
Go Digit General Insurance's board approves merger with its holding company, Go Digit Infoworks Services, marking the first such deal after insurance law amendments. The move aims to streamline structure and cut costs.
Fermenta Biotech Ltd. has been recognized as one of India's Best Workplaces in Pharmaceuticals, Healthcare & Biotech 2024 by Great Place To Work. Discover what makes their culture stand out.
India sets a 2026 health roadmap focusing on stringent drug quality, TB elimination, obesity, and a ₹4,200 crore innovation push. Will execution match ambition?
Everfast Freight Forwarders launches a major cold chain expansion in India, enhancing storage for medicines and vaccines. Discover how this investment supports healthcare logistics.
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
Afghan Health Minister admits strained Pakistan ties, pivots to India for reliable medicine and vaccine supplies. A major shift in regional health diplomacy unfolds. Read the full analysis.
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Indian government intensifies scrutiny on pharmaceutical sector, auditing 700+ cough syrup manufacturers. Health Ministry reveals 19 drug samples collected for testing amid child safety concerns. Read the full report.
Granules India establishes two advanced research centres at IIT Hyderabad's Technology Research Park, focusing on peptide development and particle engineering to enhance global pharma innovation.
Prime Minister Narendra Modi highlights Gramajanya Farmers' Producer Company in Puttur during Mann Ki Baat. Director Ramapratheek Kariyal calls it a major boost for farmer activities. Read more.
A 51-year-old Mumbai businesswoman was held at gunpoint, stripped and threatened by pharmaceutical company executives. Mumbai Police registers case under multiple sections.
NCB obtains non-bailable warrants against Digital Vision owners in massive ₹600 crore drug diversion case. Key accused involved in international pharmaceutical fraud uncovered in Himachal Pradesh.
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced single-use systems and filtration technologies.
Freudenberg Medical & Filtration Technologies unveil cutting-edge pharmaceutical solutions at CPhI PMEC India 2025, featuring advanced drug delivery systems and filtration technologies.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares list on BSE and NSE today after 93.72 times subscription. Grey market signals 20% premium debut. Full details on pricing and investor response.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.